AFP and chronic hepatitis B virus infection: The second trial, conducted in Toronto, Canada, on 1,069 participants with chronic hepatitis B, compared screening every six months with alpha-fetoprotein alone (n = 532) versus alpha-fetoprotein and ultrasound (n = 538) over a five-year period.